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ABSTRACT
Background
In endemic areas, placental malaria due to Plasmodium falciparum is most frequent and
severe in first-time mothers, and increases the risk of infant mortality in their offspring.
Placental malaria may increase the susceptibility of infants to malaria parasitemia, but evidence
for this effect is inconclusive.
Methods and Findings
During 2002–2004, we monitored parasitemia in 453 infants, including 69 who were born to
mothers with placental malaria, in a region of northeastern Tanzania where malaria
transmission is intense. We used a Cox proportional hazards model to evaluate the time
from birth to first parasitemia, and a generalized estimating equations logistic regression model
to evaluate risk of any parasitemia throughout the first year of life. Compared with infants
whose mothers did not have placental malaria at delivery (‘‘PM-negative’’), offspring of
mothers with placental malaria at delivery (‘‘PM-positive’’) were 41% more likely to experience
their first parasitemia at a younger age (adjusted hazard ratio [AHR] ¼ 1.41, 95% confidence
interval [CI] 1.01–1.99). The odds of parasitemia throughout infancy were strongly modified by
the interaction between placental malaria and gravidity (p for interaction ¼ 0.008, Type 3
likelihood ratio test). Offspring of PM-negative primigravidae had lower odds of parasitemia
during infancy (adjusted odds ratio [AOR] ¼ 0.67, 95% CI 0.50–0.91) than offspring of PM-
negative multigravidae, and offspring of PM-positive primigravidae had the lowest odds (AOR¼
0.21, 95% CI 0.09–0.47). In contrast, offspring of PM-positive multigravidae had significantly
higher odds of parasitemia (AOR ¼ 1.59, 95% CI 1.16–2.17).
Conclusion
Although parasitemia is more frequent in primigravid than multigravid women, the converse
is true in their offspring, especially in offspring of PM-positive women. While placental malaria
is known to increase mortality risk for first-born infants, it surprisingly reduced their risk of
parasitemia in this study. Placental malaria of multigravidae, on the other hand, is a strong risk
factor for parasitemia during infancy, and therefore preventive antimalarial chemotherapy
administered to multigravid women close to term may reduce the frequency of parasitemia in
their offspring.
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The hallmark of pregnancy malaria due to Plasmodium
falciparum is the accumulation of infected erythrocytes (IEs) in
the placenta [1]. Placental IEs are a distinct parasite form that
binds to chondroitin sulfate A (CSA) on syncytiotrophoblast
and in intervillous spaces [2]. Placental IEs do not adhere to
CD36, a ubiquitous receptor on the microvascular endothe-
lium that commonly supports adhesion of IEs from non-
pregnant individuals [2]. Adhesion to CSA allows parasites to
sequester in the placenta, where dense accumulations can
often occur with little or no parasitemia detectable in the
peripheral blood [3].
Because CSA-binding parasites do not commonly infect
non-pregnant individuals, women lack immunity to this
parasite form prior to the ﬁrst pregnancy [4]. In areas of
stable malaria transmission, women acquire antibodies
against placental parasites over successive pregnancies as a
consequence of repeated exposures [4,5]. Maternal antibodies
against placental IEs are associated with reduced risk of
maternal parasitemia and improved pregnancy outcomes
[6,7]. Because immunity is acquired over successive pregnan-
cies, susceptibility to malaria is greatest during the ﬁrst
pregnancy and diminishes with increasing gravidity. Simi-
larly, placental inﬂammation and the sequelae of pregnancy
malaria, such as severe maternal anemia and low birth weight,
are most frequent during ﬁrst pregnancies [8–10].
Pregnancy malaria is estimated to cause tens of thousands
or hundreds of thousands of infant deaths each year.
However, these estimates are extrapolated from the incidence
of malaria-related outcomes, such as low birth weight and
maternal anemia that increase infant mortality risk [11,12],
and the estimates sometimes differ from the real beneﬁts
observed in chemoprophylaxis trials. Low birth weight caused
by pregnancy malaria has been estimated to cause 6% of
infant deaths in sub-Saharan Africa [12], while antimalarial
chemoprophylaxis delivered to pregnant women during the
third trimester reduced infant mortality in The Gambia by
18% and 4% among offspring of primigravid and multigravid
women, respectively [13]. In Malawi, chemoprophylaxis
during pregnancy reduced infant mortality by 3%–5% [14].
The incomplete effectiveness of antimalarial regimens used
in chemoprophylaxis studies [14] and the poor sensitivity of
maternal peripheral blood slides or placental impression
slides for detecting placental malaria (PM) [15] complicate
studies that estimate the consequence of PM on infant
outcomes.
Few studies have directly examined the effects of preg-
nancy malaria on infant health. A study conducted in
southern Cameroon found no signiﬁcant difference in the
frequency of malaria between infants born to PM-positive
mothers (46.5%) and infants born to PM-negative mothers
(38.5%) during the ﬁrst two years of life (v
2 ¼ 0.24, p ¼ 0.60)
[16]. However, the age-speciﬁc prevalence of P. falciparum
parasitemia was consistently higher between 4 and 18 mo of
age among infants born to mothers with PM. The overall
malaria-free survival rates were not signiﬁcantly different
between the two groups of infants, although a considerable
decrease was observed between 5 and 8 mo of age among
infants born to placenta-infected mothers [16]. In a subset
analysis of the same infant cohort, cord serum reactivity
against two CSA-binding parasite isolates (but not reactivity
against other parasites) was related to a younger age at ﬁrst
parasitemia in the infant (p , 0.01) and to increased
frequency of parasitemia during infancy [17]. The authors
inferred that PM occurring during the last months of
pregnancy may have increased antibody against CSA-binding
parasites, and at the same time may have increased infant
susceptibility to malaria due to immunologic tolerance or
congenital transmission of parasites [17]. Results from these
studies suggest that PM may increase malaria risk in the
offspring, but further investigation is warranted. Therefore,
we examined the effect of PM on the malaria susceptibility of
offspring in a prospective cohort study of newborn infants in
northeastern Tanzania.
Methods
Clinical and Laboratory Methods
The population for the present analysis was taken from the
ongoing Mother-Offspring Malaria Study (MOMS) Project
carried out in Muheza district, northeastern Tanzania, an
area of intense malaria transmission. The entomologic
inoculation rate in the area has been described as approx-
imately 400 infective mosquito bites each year [18]. Recruit-
ment of study participants began in September 2002. The
study population for this report consisted of mother–infant
pairs enrolled during delivery hospitalization at the Muheza
Designated District Hospital. Pregnant women eligible for the
study were between the ages of 18 and 45 y and had no
evidence of chronic or debilitating illness, such as recent
signiﬁcant weight loss, chronic diarrhea, or history of chronic
illness. Written informed consent was obtained from the
mother prior to entering the study. Information on maternal
characteristics (age, village of residence, gravidity) and history
of intermittent presumptive therapy (IPT) during pregnancy
was collected during in-person interviews by trained nurses at
enrollment. Bed net usage was assessed by village health
workers during clinical visits and onsite home visits.
Placental and infant parasitemia were deﬁned as the
presence of any parasites identiﬁed in a blood slide by
microscopy. Placental blood samples were obtained after
delivery by mechanically grinding full-thickness placental
tissue [2]. Infant blood samples were collected by heel prick
every 2 wk and at the time of any illness. Thick and thin
smears were prepared for all samples; thin smears were ﬁxed
with methanol. Blood slides were stained for 10 min in 10%
Giemsa, washed in tap water and air-dried, then examined
using light microscopy at 1003 magniﬁcation. Ten thousand
red cells were examined in the thin smear before concluding
that a placental blood slide was negative, and 100 high power
ﬁelds were examined in the thick smear before concluding
that a peripheral blood slide of an infant was negative.
Infants were seen at birth and at 2-wk intervals for full
clinical examination and blood sampling, either at the
Muheza Designated District Hospital or at the Project-
sponsored mobile clinics that rotated through study villages
on a weekly basis. Assistant medical ofﬁcers performed the
clinical examination and management of infants, under the
supervision of a medical doctor. Infants with parasitemia and
signs or symptoms suggestive of clinical malaria (most
commonly fever   37.5 8C) were treated with 25 mg/kg
amodiaquine over 3 d (10, 10, and 5 mg/kg on successive days).
When amodiaquine failed to cure malaria, infants received
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Infants were hospitalized and received quinine and other
supportive care when malaria was complicated by severe
anemia (Hgb , 5 g/dl), respiratory distress, seizures or coma,
hyperparasitemia (. 2,500 parasites per 200 white blood
cells), vomiting that precluded oral medications, or prostra-
tion.
Protocols for procedures used in this study were approved
by the International Clinical Studies Review Committee of
the Division of Microbiology and Infectious Diseases at the
US National Institutes of Health, and ethical clearance was
obtained from the Institutional Review Boards of Seattle
Biomedical Research Institute and the National Institute for
Medical Research in Tanzania.
Analytical Population
Infants whose data are reported in this study were enrolled
between September 2002 and September 2003, and were
followed throughout the ﬁrst year of life. During the
recruitment period, 495 mothers gave consent to participate
and delivered at the Muheza Designated District Hospital.
Excluded from the analyses were ten twin infants, four
stillbirths, three early neonatal deaths, and six neonates who
were not examined beyond 4 wk of age because their families
moved out of the study area. Infants with any evidence of HIV
infection (mother seropositive on voluntary testing [n ¼ 7],
infant presented with suggestive signs or symptoms [n¼8], or
suffered HIV/AIDS-related death [n ¼ 4] during follow-up)
were also excluded (n ¼ 19 total). During the period of this
study, HIV-seropositivity rates were 7.5% among women who
agreed to undergo antenatal testing. After exclusions, a total
of 453 infants remained for analyses presented in this report.
Statistical Analysis
We examined the frequency distribution of maternal and
infant characteristics according to PM status (parasitemia or
no parasitemia) or gravidity (primigravid, secundigravid, or
multigravid) using a chi-squared test for categorical variables
and Student’s t-test for continuous measurements. The Mann-
Whitney test was used to assess differences in parasite density
among women with PM. Median time to ﬁrst parasitemia was
obtained using Kaplan-Meier survival analysis and assessed
with the log rank test. Follow-up time was calculated in weeks
from birth until date of ﬁrst positive diagnosis of parasitemia,
date of death, date last known to be alive, September 30, 2004
(end of follow-up period), or 54 wk of age, whichever
occurred ﬁrst.
Cox regression analysis was used to determine whether the
risk of ﬁrst parasitemia was associated with PM at delivery.
The dependent variable was time between birth and ﬁrst
positive diagnosis measured in weeks. The following variables
were considered to be potential confounders a priori and
were included in the model: gravidity (primigravid, secundi-
gravid, multigravid), transmission season at time of birth
(high or low), and bed net use in a household. According to
the incidence of parasitemia among 3- to 12-mo-old infants
in Muheza (unpublished data), the high transmission seasons
in both 2003 and 2004 occurred from May through October,
and the low transmission seasons occurred from November
through April. Residence location was grouped into six
categories by geographical area and distance to nearest
health center. In order to allow for a different baseline hazard
for each location, we used a stratiﬁed Cox regression model
[19]. All variables were assessed for conformity to the
proportional hazards assumption using the global p (PH)
statistic based on the Schoenfeld residuals. The likelihood
ratio test was used to assess for effect modiﬁcation.
Information on bed net use was missing for almost 14% of
the study population, and the bed net data were therefore
analyzed using a missing indicator, by assigning values of yes,
no, and unknown.
To assess the effect of PM at delivery on the probability of
infant parasitemia throughout infancy, generalized estimat-
ing equations logistic regression models were constructed
with a ﬁrst-order autoregressive working correlation struc-
ture (the analysis with exchangeable and m-dependent
correlation structure produced nearly identical results for
the data) and model-based standard errors [20]. This method
allowed full use of the data while accounting for the
correlation of repeated measurements over time. The multi-
variate model incorporated the main effect of PM at delivery,
as well as gravidity and other confounding factors including
bed net usage, age and transmission season at time of
bloodsmear, location of residence, and transmission season
at time of birth. A quadratic term for age ((age)
2) was also
included in the model because there appeared to be a
curvilinear relationship between age and parasitemia. Off-
spring of secundigravidae versus multigravidae had similar
probability of parasitemia during infancy (p . 0.98 and p .
0.38 when the mother was PM-positive or PM-negative,
respectively), and therefore were combined for the ﬁnal
analysis. We assessed for effect modiﬁcation between PM and
gravidity by including an interaction term in the regression
model and tested for signiﬁcance using a Type 3 likelihood
ratio test. Because the interaction term was signiﬁcant (p ¼
0.008), results are presented stratiﬁed by primigravidae (no
previous pregnancies) and secundi/multigravidae (one or
more previous pregnancies). Treatment intensity (number
of antimalarial treatments per week) was also assessed as a
potential effect modiﬁer in the different gravidity groups.
Offspring of the four groups (PM-positive primigravid, PM-
positive multigravid, PM-negative primigravid, PM-negative
multigravid) did not signiﬁcantly differ in the frequency of
antimalarial treatments using the Kruskal-Wallis test (p ¼
0.20). Therefore, treatment intensity would not have a
signiﬁcant bias effect on the assessment of the relationship
between gravidity, PM status, and other factors, and was not
included in the ﬁnal models.
All p-values are two-sided, and conﬁdence intervals (CIs)
were calculated at the 95% level. Statistical signiﬁcance was
set at p   0.05. Data analyses were conducted using STATA
version 8.0 (Stata Corporation, College Station, Texas, United
States), Statview version 5.0, and SAS version 9.0 software
(SAS Institute, Cary, North Carolina, United States).
Results
PM was identiﬁed in 69 (15.2%) of the mothers. PM-
positive women were more likely to be younger and to be
experiencing ﬁrst-time pregnancies than PM-negative women
(Table 1). Among primigravid and secundigravid women, the
frequency of PM was similar (24.2% and 23.6%, respectively),
whereas only 5.6% of multigravid women had PM at delivery.
The mean placental parasite density among PM-positive
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red cells infected), compared with secundigravidae (2.2%)
and multigravidae (1.6%) combined (Mann-Whitney, tied p ¼
0.03). Although the mean placental parasite density of PM-
positive women did not differ signiﬁcantly between birth
months, the four highest density placental parasitemias
occurred in three primigravidae (35.0%, 52.8%, and 76.5%
parasitemias) and one secundigravida (23.3% parasitemia)
during the high transmission seasons. Reported usage of
sulfadoxine-pyrimethamine for IPT against malaria during
pregnancy was high (69.7%), but did not signiﬁcantly differ
between PM-positive and PM-negative mothers. Reported IPT
usage was also similar among different gravidity groups (63%,
73%, and 72% for primigravidae, secundigravidae, and
multigravidae, respectively), as was bed net usage (62%,
59%, and 58%, respectively). Residence area was not
associated with gravidity group (chi-squared test, p ¼ 0.12).
Offspring of PM-positive mothers were similar to those of
PM-negative mothers by several measures, including gender,
birth month, and residence (Table 1). Of the 445 infants
whose birth weights were available, the mean birth weight was
3.2 kg (range 2.0–4.5 kg). Twenty-six (5.8%) weighed less than
2.5 kg, which is the standard criterion for low birth weight.
Infants of PM-positive mothers weighed signiﬁcantly less on
average at birth than those of PM-negative mothers (Table 1).
The overall mean duration of follow-up of infants was 50 wk
(range 4–54) and did not differ by PM status at delivery (p ¼
0.67). Sixty-three (13.9%) infants were lost to follow-up
between 4 and 54 wk of age (moved or parent[s] withdrew
consent), including six of the 69 infants born to PM-positive
mothers. Thirteen infants died before reaching 54 wk of age;
three (4.4%) of those from PM-positive mothers and ten
(2.6%) of those from PM-negative mothers.
Risk of First Parasitemia
Two hundred and sixty (57.4%) infants in the study cohort
experienced at least one episode of parasitemia by the age of
54 wk. Of the 193 infants who did not experience parasitemia,
138 (71.5%) were followed for at least 1 y. The median time to
ﬁrst parasitemia was 38 wk (95% CI 34–42) with a 75%
probability of remaining free of parasitemia up to 18 wk of
age. Of the 63 infants lost to follow-up, 17 (27.0%) presented
with parasitemia before dropping out of the study.
The median time to ﬁrst parasitemia for infants born to
PM-positive mothers was 32 wk (95% CI 21–38) compared
with 39 wk (95% CI 35–46) for offspring of PM-negative
mothers (Figure 1). The effect of PM on the time to ﬁrst
parasitemia in the offspring appeared to vary across gravidity
groups (Figure 2). For offspring of primigravidae, the median
time to ﬁrst parasitemia for infants born to PM-positive
mothers was 34 wk (95% CI 23–52) compared with 38 wk
(95% CI 30–49) for infants born to PM-negative mothers (p¼
0.48). Among offspring of secundigravidae, the median time
to ﬁrst parasitemia for infants born to PM-positive mothers
was 27 wk (95% CI 14–54) compared with 52 wk (95% CI 38–
54) for infants born to PM-negative mothers (p ¼ 0.06).
Table 1. Characteristics of Study Participants
Category Characteristic Subclass Analytical Population PM-Negative PM-Positive p-Value
General Number of mother-infant pairs 453 384 69
Maternal characteristics Maternal age (y) 25.9 (6.2)
a 26.4 (6.3) 22.7 (4.4) ,0.001
Maternal weight (kg) 55.6 (6.8) 55.8 (6.8) 54.3 (6.6) NS
Gravidity (%) Primigravid 28.3 25.2 44.9 ,0.001
Secundigravid 24.3 21.9 37.7
Multigravid 47.5 52.9 17.4
Residence area (%) [451] Magila-Nkumba 17.3 15.7 26.5 NS
Muheza 45.5 46.6 38.2
Mkanyangeni 6.0 5.7 7.4
Bwembwera-Potwe 16.4 17.2 11.8
Mkuzi 9.3 9.1 10.3
Mtindiro 5.5 5.5 5.9
Mother used IPT
b (%) [347]
c 69.7 70.1 64.3 NS
Bed net usage (%) [392] 59.4 60.8 51.7 NS
Infant characteristics Gender (%) [452] Male 50.7 49.9 46.4 NS
Female 49.3 50.1 53.6
Birth month (%) Jan–Feb 16.8 16.9 15.9 NS
Mar–Apr 18.5 20.1 10.1
May–June 12.4 11.2 18.8
July–Aug 13.9 13.0 18.8
Sept–Oct
d 22.1 23.2 15.9
Nov–Dec 16.3 15.6 20.3
Infant birth weight (kg) 3.2 (0.4) 3.2 (0.4) 3.0 (0.4) 0.001
Parasitemia during follow-up (%) 57.4 55.2 69.6 0.03
Infant mortality (%) 2.9 2.6 4.4 NS
Lost to follow-up (%) 13.9 14.8 8.7 NS
Duration of follow-up (wk) 49.8 (11.2) 49.7 (11.2) 50.4 (11.1) NS
aNumbers in parentheses denotes standard deviation.
bIPT, intermittent presumptive treatment for malaria during pregnancy. Mothers who reported using antimalarials to treat acute malaria during pregnancy were excluded from this analysis.
cValues in brackets denote total participants with valid values for this variable.
dIncludes three months (September 2002 and 2003 and October 2002).
NS, not significant.
DOI: 10.1371/journal.pmed.0020407.t001
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parasitemia for infants born to PM-positive mothers was 22
wk (95% CI 10–38) compared with 37 wk (95% CI 32–46) for
infants born to PM-negative mothers (p ¼ 0.01).
Using stratiﬁed Cox regression, the estimated hazard ratio
of ﬁrst parasitemia for infants born to PM-positive mothers
was 1.41 (95% CI 1.01–1.99) times that of infants born to PM-
negative mothers, after adjustment for gravidity, transmission
season at time of birth, area of residence, and bed net usage
(Table 2). Although the test for interaction between gravidity
and placental infection was not statistically signiﬁcant (like-
lihood ratio test, p ¼ 0.27), the effect of PM on infant risk
appeared to vary across gravidity groups after adjustment for
potential confounders (Figure 2B, 2D, and 2F). Among
offspring of multigravid women, the risk of ﬁrst parasitemia
for infants born to PM-positive mothers was more than twice
that of infants born to PM-negative mothers, and remained
signiﬁcant after adjustment for transmission season at time of
birth, area of residence, and bed net usage (adjusted hazard
ratio [AHR] ¼ 2.20, 95% CI 1.15–4.20). The risk of ﬁrst
parasitemia among offspring of primigravid or secundigravid
women was not signiﬁcantly associated with PM after adjust-
ment for potential confounding factors (AHR¼1.15, 95% CI
0.66–2.00, AHR ¼ 1.15, 95% CI 0.61–2.17, respectively).
Risk of Any Parasitemia
The age-speciﬁc prevalence of parasitemia during infancy
differed by gravidity and PM status of the mother regardless
of transmission season (Figure 3). Blood-slide positivity was
observed more frequently among offspring of PM-positive
multigravidae than among offspring of PM-positive primi-
gravidae, in all age groups above 2 months of age. This
relationship was observed in analyses of all bloodsmears
collected from infants in either the low transmission (Figure
3C) or high transmission season (Figure 3D).
Results from generalized estimating equations logistic
regression analysis of the interaction between gravidity and
PM on the odds of parasitemia are presented in Table 3. After
adjustment for age, transmission season at birth and at time
of bloodsmear, bednet usage, and residence, offspring of PM-
negative primigravid women had signiﬁcantly reduced odds
of parasitemia during the ﬁrst year of life (adjusted odds ratio
[AOR] ¼ 0.67, 95% CI 0.50–0.91), and the odds were lowest
among offspring of PM-positive primigravid women (AOR ¼
0.21, 95% CI 0.09–0.47). In contrast, PM at delivery in
multigravid women was associated with signiﬁcantly in-
creased odds of parasitemia in their offspring (AOR ¼ 1.59,
95% CI 1.16–2.17).
Discussion
In this prospective cohort study of 453 mother–offspring
pairs, both PM and maternal gravidity inﬂuenced the risk of
P. falciparum parasitemia during infancy. Overall, offspring of
PM-positive mothers experienced their ﬁrst parasitemia at a
signiﬁcantly younger age than offspring of PM-negative
mothers, and the risk of early ﬁrst parasitemia was highest
among offspring of PM-positive multigravidae. The risk of
any parasitemia during infancy was strongly modiﬁed by an
interaction between PM and gravidity. Offspring of PM-
negative primigravidae had a decreased risk of parasitemia,
while offspring of PM-positive primigravidae had the lowest
risk. In contrast, offspring of PM-positive multigravidae had
an increased risk of parasitemia.
Our results are the ﬁrst to identify an effect of maternal
gravidity to modify malaria risk in offspring during infancy.
An earlier study in southern Cameroon observed an
increased age-speciﬁc prevalence of P. falciparum in infants
born to PM-positive mothers [16], but did not assess the effect
of gravidity. Surprisingly, in the present study, PM decreased
malaria risk in offspring of primigravidae but increased risk
in offspring of other gravid groups. The opposing effects of
Figure 1. Kaplan-Meier Estimate of the Probability of Surviving without Parasitemia
The graph shows the age at first parasitemia in offspring of PM-positive mothers (solid line) versus PM-negative mothers (dashed line).
Infants born to PM-positive mothers experience their first parasitemia at a significantly younger age than infants of PM-negative mothers (log rank, p¼
0.02).
DOI: 10.1371/journal.pmed.0020407.g001
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may explain why earlier studies failed to ﬁnd signiﬁcant
relationships between PM and malaria risk during the ﬁrst
two years of life [16].
Because PM had been suggested to increase susceptibility
during infancy [16,21], we expected offspring of PM-positive
primigravidae to be at highest risk, since PM is most frequent
and placental parasite densities are highest during primi-
gravid pregnancies. In Malawi, high placental parasite
densities were associated with increased risk of cord blood
parasitemia [22], supporting the conjecture that congenital
malaria could account for the relationship between PM and
susceptibility of infants [17]. Although we expected PM to
increase susceptibility in offspring of primigravid women to
the greatest degree, we observed the opposite pattern. Our
data are consistent with those of an earlier study [17] showing
that cord blood levels of antibody against CSA-binding
parasites were positively related to child susceptibility to
malaria. Antibody against CSA-binding parasites is highest in
multigravid women [4], and we ﬁnd that offspring of
multigravid women have the highest risk of parasitemia.
The results from the earlier study were interpreted to suggest
that antibody against CSA-binding parasites reﬂected a
recent maternal parasitemia that may induce immunologic
tolerance or congenital malaria [17], or else reﬂected an
increased exposure to malaria for both the mother and the
offspring [23]. However, neither interpretation would fully
explain our ﬁnding that an interaction between gravidity and
PM modiﬁes infant susceptibility to parasitemia.
PM during the antenatal period may be inﬂuencing infant
outcomes, separate from any effect of neonatal exposure
occurring at delivery, and could explain the reduced risk of
Figure 2. Kaplan-Meier Estimate of the Probability of Surviving without Parasitemia and Adjusted Estimate Using a Cox Model
The graphs show the unadjusted (left panels) and adjusted (right panels) age at first parasitemia in first-born (A and B), second-born (C and D), or third-
born or subsequent (E and F) offspring of PM-positive mothers (solid lines) versus PM-negative mothers (dashed lines).
PM is associated with a significantly younger age at the time of first parasitemia among offspring of multigravidae (log rank, p¼0.01), but not among
offspring of primigravidae (log rank, p¼0.48) or secundigravidae (log rank, p¼0.06). Adjustment estimates using a Cox model did not change statistical
significance in any gravidity group.
DOI: 10.1371/journal.pmed.0020407.g002
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In areas of stable transmission, primigravid women are
parasitemic more frequently [24], and experience higher
parasite densities, more severe inﬂammatory responses [8],
and greater clinical sequelae [13,25] than women in other
gravid groups. In the current cohort, 24.2% of primigravid
women had PM with a mean parasite density of 7.1% at the
time of delivery, compared with 5.6% of multigravid women
with a mean parasite density of 1.6%, reﬂecting the
susceptibility of primigravid women. Although we cannot
exclude the possibility that an intrinsic effect of gravidity may
modify malaria susceptibility of offspring, we favor the
explanation that PM during the antenatal period is modulat-
ing the susceptibility of the offspring, because PM at delivery
is having a similar (but more profound) effect. We propose
that differences in the load of malarial antigen or the
intensity of the inﬂammatory response may account for the
differences observed between gravid groups, but this remains
to be determined.
Factors such as area of residence, season of observation,
and HIV may increase the risk of parasitemia in both mother
and offspring, and therefore may confound an analysis of
maternal parasitemia and infant susceptibility. However, our
adjusted analyses suggest that these confounding factors
would not fully explain the results. Although the incidence of
parasitemia during infancy differed signiﬁcantly between
Table 2. Unadjusted and Adjusted Hazard Ratios for Risk of First Parasitemia during Infancy
Characteristic Risk Factor Total Population (%) Unadjusted Hazard Ratios (95% CI) Adjusted Hazard Ratios (95% CI)
a
PM No
b 384 (85) 1.00
Yes 69 (15) 1.33 (0.97, 1.83) 1.41 (1.01, 1.99)
Transmission season at birth Low
b 234 (52) 1.00
High 219 (48) 0.67 (0.52, 0.86) 0.67 (0.52, 0.86)
Gravidity Multigravid
b 215 (48) 1.00
Secundigravid 128 (28) 0.91 (0.66, 1.24) 0.84 (0.60, 1.16)
Primigravid 110 (24) 0.89 (0.66, 1.19) 0.85 (0.62, 1.16)
Bed net usage
c No
b 159 (35) 1.00
Yes 233 (51) 0.67 (0.51, 0.87) 0.70 (0.53, 0.92)
Unknown 61 (14) 0.66 (0.41, 1.06) 0.72 (0.45, 1.16)
aHazard ratios were adjusted for residence area and all the other variables in the table.
bReference category.
cInformation on use of bed nets was available for 392 of the 451 mother–infant pairs in the study.
DOI: 10.1371/journal.pmed.0020407.t002
Figure 3. Age-Specific Parasite Positivity
These graphs show age-specific parasite positivity of all blood slides obtained from infants born to primigravid women (dashed lines) versus
secundigravid or multigravid women (solid lines).
The frequency of parasitemia among offspring of PM-negative mothers (A and B) or offspring of PM-positive mothers (C and D) is presented according
to whether the slides were collected during the low-transmission season (A and C) or high-transmission season (B and D). Low transmission of malaria
around Muheza occurs from November through April, and high transmission occurs from May through October. Parasitemia was more frequent among
the offspring of secundigravid and multigravid women versus primigravid women when PM was present at delivery. This relationship was observed in
all age groups except neonates, and was observed in both low- (C) and high- (D) transmission seasons. Figures represent frequency of positivity for all
slides collected during the study period, including slides collected subsequent to treatment.
DOI: 10.1371/journal.pmed.0020407.g003
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Infant Susceptibility to Malariavillages in this study (unpublished data), the frequency of PM
did not (Table 1). Nor did the frequency of PM vary
signiﬁcantly by birth month (Table 1). While infants born
during the low transmission season had a higher risk of
parasitemia (presumably due to the seasonality of trans-
mission), the increased frequency of parasitemia observed in
offspring of PM-positive secundi- and multigravidae was
apparent in both high and low transmission seasons (Figure
3), suggesting that the relationship between PM and infant
susceptibility in the different gravidity groups was independ-
ent of seasonality. The intensive longterm follow-up of
infants was likely to identify the majority of infants with
HIV infection, as progression to disease is rapid in infants,
especially African infants [26]. Eleven of the 12 offspring of
PM-positive multigravidae included in our analyses had been
followed for 18 mo or more, and none of the 12 experienced
signs or symptoms of HIV infection. In sum, confounding
factors associated with risk of parasitemia do not fully explain
the gravidity-dependent relationships observed in this study,
and speciﬁcally run counter to the observation that offspring
of PM-positive primigravidae have a decreased risk of
parasitemia.
Behavioral and environmental factors may vary with
gravidity and could account for some gravidity-dependent
relationships. An increased number of children in multi-
gravid households would possibly attract more mosquitoes or
increase the proportion of mosquitoes that are infective,
thereby increasing malaria exposure among offspring of
multigravidae. However, this would not explain why PM at
delivery decreases malaria risk in offspring of primigravidae.
Conversely, the increased frequency of fever in primigravid
women may cause them to consume more antimalarials,
which could be transferred to the fetus or infant and reduce
infant parasitemia. However, reported usage of antimalarials
during pregnancy was similar among the different gravidity
groups. Furthermore, PM was associated with a risk of
parasitemia throughout infancy, and is unlikely to be
accounted for by ingestion of antimalarials at term.
Our ﬁndings suggest that PM decreases susceptibility in the
offspring of primigravidae, and increases susceptibility in the
offspring of multigravidae. Among primigravidae, the pro-
nounced inﬂammatory response to PM could confer protec-
tion, for example by reducing parasitemia [27] and thereby
preventing congenital transmission. Alternatively, sensitiza-
tion of the fetal or neonatal immune system may be
modulating immunity in a way that modiﬁes susceptibility
to parasitemia, such as by inducing regulatory T (Treg) cells,
which have been related to malaria susceptibility in rodents
[28,29]. Inﬂammatory signals inhibit the development of Treg
cells [30], and thus the inﬂammatory responses that are
common in primigravid but not multigravid women with PM
could lead to differential effects of sensitization in their
offspring. Separately, studies in Kenya have shown that
antibodies against the P. falciparum MSP-1 antigen were lower
among offspring of PM-positive mothers [21], and it will be
valuable to determine whether anti-MSP-1 antibody re-
sponses in infants vary according to both PM and maternal
gravidity. Future studies should seek to better understand
congenital transmission of P. falciparum, as well as the effect of
placental inﬂammation to modulate the infant’s antibody and
cellular responses against the parasite.
The ﬁndings of the present study establish a conundrum.
PM at delivery greatly reduced the odds of parasitemia in
offspring born to primigravid women, yet earlier studies
reported that PM was the strongest risk factor for severe
morbidity [31–34] and mortality of ﬁrst-born infants [13].
More research is needed to understand the impact of PM on
malaria-related and other clinical outcomes during infancy.
The gravidity-dependent pattern of infant susceptibility
identiﬁed here may provide a useful tool to study the
relationship between the frequency of P. falciparum para-
sitemia and disease in young children.
In summary, PM decreases the risk of parasitemia among
offspring of primigravidae but increases the risk among
offspring of multigravidae. Traditionally, pregnancy malaria
has been thought to affect the offspring primarily through
low birth weight or maternal anemia, which are risk factors
for neonatal and infant mortality. The present ﬁndings
indicate that pregnancy malaria may also have prolonged
effects on immunity and susceptibility to malaria in the
offspring, and that these effects are strongly inﬂuenced by
maternal gravidity. Further investigation of these relation-
ships with assessment of other potential confounders, as well
as their impact on infant morbidity and mortality, is needed
with larger cohort studies. A preventive dose of antimalarial
chemotherapy delivered to secundigravid or multigravid
women in the last 1–2 wk before term may reduce P.
falciparum parasitemia in their offspring, but more research
is needed to predict its effect on malaria-related disease and
death. The beneﬁts of malaria prevention during pregnancy
may extend beyond its effect on birth outcomes, and should
be studied in randomized clinical trials with careful attention
to PM status at delivery and outcomes during early childhood.
Table 3. Unadjusted and Adjusted Odds of Any Parasitemia during Infancy Associated with Placental Malaria, Stratified by Gravidity
Stratification Unadjusted Adjusted
a
OR 95% CI OR 95% CI
No PM/multigravid 1.0 (Reference) 1.0 (Reference)
No PM/primigravid 0.70 (0.51, 0.95) 0.67 (0.50, 0.92)
PM/primigravid 0.25 (0.10, 0.58) 0.21 (0.09, 0.47)
PM/multigravid 1.76 (1.28, 2.42) 1.59 (1.16, 2.17)
Primigravid ¼ 0 previous pregnancies; multigravid ¼ 1þ previous pregnancies.
aAdjusted for age, (age)
2, bed net usage, season at time of birth and at time of bloodsmear, and residence.
OR, odds ratio.
DOI: 10.1371/journal.pmed.0020407.t003
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Patient Summary
Background In areas where malaria is common, most adult women have
acquired some level of immunity against the malaria parasite. However,
during pregnancy, many experience a new type of malaria infection in
their placenta. This placental malaria is particularly severe during first-
time pregnancy. Pregnant women with placental malaria often give birth
to babies with a low birth weight, and these babies have an increased
risk of dying as infants.
Why Was This Study Done? The connection between placental malaria
and low birth weight is well established. However, it is not clear whether
placental malaria makes it more likely for infants to get infected with
malaria parasites themselves, and this is the question the researchers
addressed in this study.
What Did the Researchers Do and Find? They studied a total of 453
infants, of which 69 were born to mothers with placental malaria. Of
those 69 infants, 31 were born to first-time mothers, and 38 to mothers
who had given birth before. The researchers then followed those infants
for a year and checked how often during that time they had parasites in
their blood. Surprisingly, the researchers found that children followed
one of two opposing patterns, depending on their birth order. Children
from first-time mothers were less likely to have parasites in their blood,
especially children whose mothers had placental malaria. Children from
other mothers were more likely to have parasites in their blood,
especially children whose mothers had placental malaria.
What Does This Mean? These results suggest that both the number of
previous pregnancies and placental malaria affect an infant’s chances of
developing malaria. It might be that in first-time mothers placental
malaria stimulates the infant’s immune system and this somehow
protects the baby against malaria, but at present this is just speculation.
Also, the study is relatively small, and the connections between the
number of previous pregnancies, placental malaria, and the chances of
an infant getting malaria need to be tested in other studies.
Where Can I Find More Information Online? The following Web sites
provide information about malaria.
Wikipedia pages on malaria:
http://en.wikipedia.org/wiki/Malaria
WHO pages on malaria, which contain a section on malaria and
pregnancy:
http://www.who.int/topics/malaria/en/
MedlinePlus pages on malaria:
http://www.nlm.nih.gov/medlineplus/malaria.html
UNICEF page on malaria with links:
http://www.childinfo.org/eddb/Malaria/
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